BioTechne Corp (TECH)
(Delayed Data from NSDQ)
$78.30 USD
-2.06 (-2.56%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $78.29 -0.01 (-0.01%) 6:06 PM ET
3-Hold of 5 3
D Value D Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Bio-Techne Corp [TECH]
Reports for Purchase
Showing records 81 - 100 ( 189 total )
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 6122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Cell Therapy and Bioprocess Adding Momentum
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Protein vs. Dx/Genomics or Buy vs. Sell
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Life Science Product Momentum; Raise Rating to OW with $600 Price Target
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department